IOVA β€” IOVANCE BIOTHERAPEUTICS INC

Ownership history in nVerses Capital, LLC  Β·  5 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in IOVANCE BIOTHERAPEUTICS INC (IOVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.07% (2024 Q3)
πŸ“Š Avg. % of fund
0.07%
πŸ“… First filed
2024 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
5

Position Intelligence

nVerses Capital, LLC Γ— IOVA AI Analytics

πŸ“‰ nVerses Capital, LLC underperformed the S&P 500 by –115.5% annually on this IOVA position. Average cost basis: $9.39. Maximum drawdown during holding period: –81.7%.

πŸ“ˆ Position Alpha vs SPY
-115.5%
annualised excess return

❌ Significantly underperformed the S&P 500 by 115.5% ann.
4 quarters analyzed

πŸ’° Entry Quality
$9.39
-76.9% vs current ($2.17)

Best entry: $9.39 (2024 Q3)  Β·  Worst: $9.39 (2024 Q3)

πŸ›‘οΈ Drawdown Resilience
–81.7%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

1 add Β· 0 trims. Bought during 0 of 3 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.07% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    IOVA price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 5 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 15,800 β€” 0% 0.07% $148K $2.17
2025 Q2 UNCHANGED 15,800 β€” 0% 0.07% $148K $1.72
2025 Q1 UNCHANGED 15,800 β€” 0% 0.07% $148K $3.33
2024 Q4 UNCHANGED 15,800 β€” 0% 0.07% $148K $7.40
2024 Q3 INITIATED 15,800 β€” β€” 0.07% $148K $9.39

🏒 Other funds also holding IOVA

As of 2025 Q4 β€” sorted by position size

MHR FUND MANAGEMENT LLC 3Y 7Y 6.81% B Group, Inc. 3.02% Palo Alto Investors LP 3Y 7Y 2.7% Orion Investment Co 1.54% Invenomic Capital Management LP 3Y 1.52% CM Management, LLC 3Y 0.92% Parametrica Management Ltd 3Y 7Y 0.82% Long Focus Capital Management, LLC 3Y 0.62% Rhenman & Partners Asset Management AB 3Y 7Y 0.41% Mirador Capital Partners LP 3Y 7Y 0.39%
← Back to nVerses Capital, LLC Holdings